ReferIndia News oncology prescription business of Khandelwal Labs' for Rs 325 crore

ReferIndia News

Sponsored

Easy Steps, Real Earnings

Start Earning
News Image

oncology prescription business of Khandelwal Labs' for Rs 325 crore

Published on: Jan. 1, 2026, 7:28 p.m. | Source: Times of India

India Business News: HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a goin.

Checkout more news
Ad Banner

Looking for a side income?

Work on your own terms — become a freelancer with us! Choose projects you love, set your own schedule, and start earning today. No fixed hours, no limits — just flexibility and freedom.

Know more
ReferIndia News contact